Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01448213 · ClinicalTrials.gov registry record · Phase 2
Comparison of Two Steroid Regimens to Prevent Transplant Rejection After Corneal Transplant (DMEK)
A Phase 2 study, sponsored by Price Vision Group.
- Completed
- Registry status
- Phase 2
- Development phase
- 264
- Enrollment target
NCT01448213 is a Phase 2 study that has completed, run by Price Vision Group. The registered enrollment target is 264 participants.
The verdict
NCT01448213, a Phase 2 study, has completed, sponsored by Price Vision Group.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 264 participants
- Enrollment target
Study Summary
The purpose of this study is to compare two different commonly used steroid dosing regimens after Descemet's membrane endothelial keratoplasty (DMEK) transplant surgery. The investigators hope to determine if one is more effective at preventing rejection or if both are equally effective.
Interventions
- DRUG Prednisolone acetate
- DRUG Fluorometholone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 264 participants |
| Start Date | 2011-10 |
| Est. Completion | 2014-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01448213
The ClinicalTrials.gov registry entry for NCT01448213 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 264 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Price Vision Group, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Prednisolone acetate is the first listed.
NCT01448213 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01448213 about?
NCT01448213 is a clinical study titled "Comparison of Two Steroid Regimens to Prevent Transplant Rejection After Corneal Transplant (DMEK)". The purpose of this study is to compare two different commonly used steroid dosing regimens after Descemet's membrane endothelial keratoplasty (DMEK) transplant surgery. The investigators hope to determine if one is more effective at preventing rejection or if both are equally effective.
What is the current status of trial NCT01448213?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 264 participants. The study started on 2011-10. Estimated completion is 2014-01.
What interventions are being tested in trial NCT01448213?
The interventions under investigation include: Prednisolone acetate (DRUG), Fluorometholone (DRUG).
Who is sponsoring clinical trial NCT01448213?
This trial is sponsored by Price Vision Group, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.